Pemazyre Approved for Treatment of Advanced Cholangiocarcinoma | Health News
Health

Pemazyre Approved for Treatment of Advanced Cholangiocarcinoma | Health News

(HealthDay) MONDAY, April 20, 2020 (HealthDay News) — Pemazyre (pemigatinib) has been granted accelerated approval for the treatment of advanced cholangiocarcinoma, the U.S. Food and Drug Administration announced Friday. The drug approval is indicated for previously treated patients with locally advanced or metastatic cholangiocarcinoma and tumors with a fusion or other rearrangement of fibroblast growth […]

Tukysa Approved for Unresectable, Metastatic HER2-Positive Breast Cancer | Health News
Health

Tukysa Approved for Unresectable, Metastatic HER2-Positive Breast Cancer | Health News

(HealthDay) MONDAY, April 20, 2020 (HealthDay News) — The U.S. Food and Drug Administration announced Friday the approval of Tukysa (tucatinib) in combination with trastuzumab and capecitabine for treatment of advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Tukysa, a kinase inhibitor, is indicated for patients who have already received […]

Coronavirus: Home abortions approved during outbreak
Health

Coronavirus: Home abortions approved during outbreak

Image copyright Getty Images Image caption Women and girls will now be able to take both abortion pills at home Patients in England can now have home abortions during the Covid-19 outbreak, the government in England has said. Abortion policy has changed several times during the current pandemic. Women and girls wanting to terminate an […]

Epclusa Approved for Children With Any Hep C Genotype | Health News
Health

Epclusa Approved for Children With Any Hep C Genotype | Health News

(HealthDay) FRIDAY, March 20, 2020 (HealthDay News) — Epclusa (sofosbuvir and velpatasvir) received approval for a supplemental application to treat hepatitis C virus (HCV) in children without cirrhosis or with mild cirrhosis, the U.S. Food and Drug Administration announced Thursday. The supplemental application of Epclusa is indicated for children ages 6 years and older or […]

Ofev Approved for Chronic Fibrosing ILDs With Progressive Phenotype | Health News
Health

Ofev Approved for Chronic Fibrosing ILDs With Progressive Phenotype | Health News

(HealthDay) TUESDAY, March 10, 2020 (HealthDay News) — Ofev (nintedanib) oral capsules have received the first approval for the treatment of patients with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, the U.S. Food and Drug Administration announced Monday. Ofev, a multitargeted tyrosine kinase inhibitor, was approved in 2014 to treat idiopathic pulmonary […]

Sarclisa Approved for Treatment of Multiple Myeloma | Health News
Health

Sarclisa Approved for Treatment of Multiple Myeloma | Health News

(HealthDay) TUESDAY, March 3, 2020 (HealthDay News) — Sarclisa (isatuximab-irfc) has been approved for the treatment of adults with multiple myeloma in combination with pomalidomide and dexamethasone, the U.S. Food and Drug Administration announced Monday. Sarclisa, in combination with pomalidomide and dexamethasone, is indicated for patients who have previously received two therapies, including lenalidomide and […]